Moreover, subcutaneous injection of ACTN4-expressing CD44+/CD24− cells resulted in an increased incidence of tumor formation, even when only 1000 cells were implanted, further verifying the tumorigenic significance of ACTN4 on breast cancer (Additional file 1: Table S2). The gene discussed is CD44; the disease is neoplasm.